Načítá se...
Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up
The manufacture of recombinant therapeutics is a fastest-developing section of therapeutic pharmaceuticals and presently plays a significant role in disease management. Yeasts are established eukaryotic host for heterologous protein production and offer distinctive benefits in synthesising pharmaceu...
Uloženo v:
| Vydáno v: | Microb Cell Fact |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246677/ https://ncbi.nlm.nih.gov/pubmed/34193127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12934-021-01617-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|